Skip to main content


Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients

The original article was published in Radiation Oncology 2013 8:296


After the publication of this work [1], a few points were brought to our attention:

The clinical data of patient 2 are incorrect. A revised version of Table 1 [1] showing the corrected patient characteristics is presented here. Consequently, the description of the patient cohort in the Materials and Methods section is incorrect. The correct description is: “Plasma miRNA analysis was performed on 18 HNSCC patients treated with local X-ray-irradiation using a linear accelerator […].

Table 1 Patient characteristics

17 out of 18 patients received concurrent chemotherapy (13 patients received 5-fluorouracil (5-FU) plus mitomycin C (MMC) [21], 3 patients MMC and 1 patient cisplatin weekly)”.

There is a typing error in the Results section [1] concerning the p value of the up-regulation of miR-425-5p. The correct sentence is:

“The qRTPCR assays confirmed an up-regulation of miR-425-5p with a p value close to the significance level (p = 0.052) […]”.

The corrections do not affect any results or conclusions of the published work.


  1. 1.

    Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol. 2013;8:296.

Download references

Author information

Correspondence to Horst Zitzelsberger.

Additional information

The online version of the original article can be found under doi:10.1186/1748-717X-8-296.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.